101 related articles for article (PubMed ID: 20857089)
1. In vitro study of P-glycoprotein induction as an antidotal pathway to prevent cytotoxicity in Caco-2 cells.
Silva R; Carmo H; Dinis-Oliveira R; Cordeiro-da-Silva A; Lima SC; Carvalho F; Bastos Mde L; Remião F
Arch Toxicol; 2011 Apr; 85(4):315-26. PubMed ID: 20857089
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin decreases paraquat accumulation and toxicity in Caco-2 cells.
Silva R; Carmo H; Vilas-Boas V; de Pinho PG; Dinis-Oliveira RJ; Carvalho F; Silva I; Correia-de-Sá P; Bastos Mde L; Remião F
Toxicol Lett; 2013 Feb; 217(1):34-41. PubMed ID: 23220037
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein induction in Caco-2 cells by newly synthetized thioxanthones prevents paraquat cytotoxicity.
Silva R; Palmeira A; Carmo H; Barbosa DJ; Gameiro M; Gomes A; Paiva AM; Sousa E; Pinto M; Bastos Mde L; Remião F
Arch Toxicol; 2015 Oct; 89(10):1783-800. PubMed ID: 25234084
[TBL] [Abstract][Full Text] [Related]
4. Effect of hr-IL2 treatment on intestinal P-glycoprotein expression and activity in Caco-2 cells.
Belliard AM; Tardivel S; Farinotti R; Lacour B; Leroy C
J Pharm Pharmacol; 2002 Aug; 54(8):1103-9. PubMed ID: 12195825
[TBL] [Abstract][Full Text] [Related]
5. Induction and activation of P-glycoprotein by dihydroxylated xanthones protect against the cytotoxicity of the P-glycoprotein substrate paraquat.
Silva R; Sousa E; Carmo H; Palmeira A; Barbosa DJ; Gameiro M; Pinto M; Bastos Mde L; Remião F
Arch Toxicol; 2014 Apr; 88(4):937-51. PubMed ID: 24464498
[TBL] [Abstract][Full Text] [Related]
6. Pregnane X receptor mediates the induction of P-glycoprotein by spironolactone in HepG2 cells.
Rigalli JP; Ruiz ML; Perdomo VG; Villanueva SS; Mottino AD; Catania VA
Toxicology; 2011 Jul; 285(1-2):18-24. PubMed ID: 21459122
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein induction: an antidotal pathway for paraquat-induced lung toxicity.
Dinis-Oliveira RJ; Remião F; Duarte JA; Ferreira R; Sánchez Navarro A; Bastos ML; Carvalho F
Free Radic Biol Med; 2006 Oct; 41(8):1213-24. PubMed ID: 17015168
[TBL] [Abstract][Full Text] [Related]
8. 20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb-drug interactions.
Zhang J; Zhou F; Wu X; Gu Y; Ai H; Zheng Y; Li Y; Zhang X; Hao G; Sun J; Peng Y; Wang G
Drug Metab Dispos; 2010 Dec; 38(12):2179-87. PubMed ID: 20837659
[TBL] [Abstract][Full Text] [Related]
9. Effect of benzo[a]pyrene on P-glycoprotein-mediated transport in Caco-2 cell monolayer.
Sugihara N; Toyama K; Michihara A; Akasaki K; Tsuji H; Furuno K
Toxicology; 2006 Jun; 223(1-2):156-65. PubMed ID: 16647797
[TBL] [Abstract][Full Text] [Related]
10. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective regulation of MDR1 expression in Caco-2 cells by cetirizine enantiomers.
Shen S; He Y; Zeng S
Chirality; 2007 Jun; 19(6):485-90. PubMed ID: 17394131
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of methylprednisolone on paraquat-induced A549 cell cytotoxicity via induction of efflux transporter, P-glycoprotein expression.
Zerin T; Kim YS; Hong SY; Song HY
Toxicol Lett; 2012 Jan; 208(2):101-7. PubMed ID: 22079615
[TBL] [Abstract][Full Text] [Related]
13. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
14. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
15. Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux.
Chavanpatil MD; Khdair A; Gerard B; Bachmeier C; Miller DW; Shekhar MP; Panyam J
Mol Pharm; 2007; 4(5):730-8. PubMed ID: 17705442
[TBL] [Abstract][Full Text] [Related]
16. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of P-glycoprotein activity by limonin and other secondary metabolites from Citrus species in human colon and leukaemia cell lines.
El-Readi MZ; Hamdan D; Farrag N; El-Shazly A; Wink M
Eur J Pharmacol; 2010 Jan; 626(2-3):139-45. PubMed ID: 19782062
[TBL] [Abstract][Full Text] [Related]
18. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Xu HB; Li L; Liu GQ
Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
[TBL] [Abstract][Full Text] [Related]
19. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M
J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998
[TBL] [Abstract][Full Text] [Related]
20. Reduction of doxorubicin resistance in P-glycoprotein overexpressing cells by hybrid cell-penetrating and drug-binding peptide.
Zheng Z; Aojula H; Clarke D
J Drug Target; 2010 Jul; 18(6):477-87. PubMed ID: 20088680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
